Required
Refer to Exhibit 18.14 and calculate Labopharm€™s profitability ratios for 2014 (round calculations to two decimal places). Also identify whether each of Labopharm€™s profitability ratios compares favorably (F) or unfavourably (U) to the industry average by referring to Exhibit 18.11.
Analysis Component: Comment on the trend in sales, accounts receivable, cost of goods sold, and accounts payable for the three years 2014, 2013, and2012.

Transcribed Image Text:

Labopharm Inc. Comparative Balance Sheet Information November 30 (millions of $) Labopharm Inc. Income Statement For Year Ended November 30, 2014 (millions of $) 2014 2013 2012 2014 2013 2012 $3,920 $6,240 $6,560 131 Cost of goods sold.2,744 4,368 4,592 Plant and equipment (net1,432 ,40 ,776 Gross profit. $1,176 $1,872 $1,968 275 131 960 1,280 1,440 160 640 169 184 Operating expenses Long-term notes payable... Preferred shares, 2 Common shares2 Retained earnings.... Depreciation expense S 296 296 296 392 1,248 1,444 1,740 96 Income from operations488 328 228 87 64 283 152 $77 160 640 92 160 640 Other expenses.. 688 1,544 58 The preferred shares are $0.50, non-cumulative 147 80 million preferred and 320 million common shares were issued and outstanding during each year Income tax expense.. Net income..